These findings provide insights into further developing genetic marker GATA2 and its interaction partners or target genes to distinguishes aggressive disease and highlight the interplays between somatic genomic alterations and inherited genetic variations that are crucial for PCa progression. The gene discussed is GATA2; the disease is posterior cortical atrophy.